1. Mitochondrial targeting of quinones: therapeutic implications.
- Author
-
Cochemé HM, Kelso GF, James AM, Ross MF, Trnka J, Mahendiran T, Asin-Cayuela J, Blaikie FH, Manas AR, Porteous CM, Adlam VJ, Smith RA, and Murphy MP
- Subjects
- Administration, Oral, Animals, Cations, Cell Membrane metabolism, Humans, Membrane Potential, Mitochondrial, Membrane Potentials, Mitochondrial Diseases therapy, Models, Biological, Models, Chemical, Oxygen metabolism, Ubiquinone metabolism, Mitochondria metabolism, Organophosphorus Compounds metabolism, Quinones chemistry, Ubiquinone analogs & derivatives
- Abstract
Mitochondrial oxidative damage contributes to a range of degenerative diseases. Ubiquinones have been shown to protect mitochondria from oxidative damage, but only a small proportion of externally administered ubiquinone is taken up by mitochondria. Conjugation of the lipophilic triphenylphosphonium cation to a ubiquinone moiety has produced a compound, MitoQ, which accumulates selectively into mitochondria. MitoQ passes easily through all biological membranes and, because of its positive charge, is accumulated several hundred-fold within mitochondria driven by the mitochondrial membrane potential. MitoQ protects mitochondria against oxidative damage in vitro and following oral delivery, and may therefore form the basis for mitochondria-protective therapies.
- Published
- 2007
- Full Text
- View/download PDF